ANXA1 and central nervous system cancer: Some studies in gliomas have shown that ANXA1 is a risk prognostic factor (Xu et al., 2017; Luo et al., 2021; Wei et al., 2021) Therefore, we investigated the expression, prognosis, and related mechanisms of ANXA1 using a public database to provide new markers and potential therapeutic targets for glioma patients.